Archive for ‘Medical Applications For Mobile Phone’

Page 1 of 1212345...10...Last »

Aromatherapy Market: Expected To Observer Major Growth By 2025

Aromatherapy Market: Expected To Observer Major Growth By 2025

Future-Market-Insights192

 

Aromatherapy is the procedure for the treatment in which essential oils are used to cure anxiety, headache, muscular pain and so on. Aromatherapy is the type of alternative medicine composed of aromatic plant oils, plant materials and other aromatic plant compounds for the purpose of improving a person’s mood and health. The oils that are used in aromatherapy have variant composition as compared to other herbal products because the purification process that is used in aromatherapy restores the lighter phytomolecules in the oils. Some evidences to support the essential oils therapeutic usage are that aromatherapy has unique characteristics that can affect both the functions psychologically as well as physiologically. Measurements to compute psychological and physiological effects are change in heart rate, epidermal activity, peripheral blood pressure, cerebral blood flow, changes in skin temperature and others. Aromatherapy procedure is known to provide benefits such as mood stimulation or sedation, cognitive performance in terms of attention and memory and performance boosting. Aromatherapy is important in healing some maladies like anxiety, insomnia, pain, stress, body and muscular aches, headaches, depression, digestive problems and many more. Aromatherapy treatment is provided by three ways namely aerial diffusion in which the oil disperses into the air to disinfect it by spreading specific fragrances, direct inhalation in which person breathes the oil directly and topical application in which oil is applied on the patient skin. Topical application is commonly used for massage, baths and therapeutic skin care. Direct inhalation will commonly help in respiration disinfection.

Aromatherapy Market: Drivers and Restraints

The primary factor for the growth of global aromatherapy market is the growing awareness about the herbal products among the individuals. The main factors driving the growth for aromatherapy are increasing geriatric population and a shift in the lifestyle of people in cities. This gives rise to problems such as anxiety, insomnia, stress, headaches etc. These common complaints have fuelled the demand for aromatherapy or herbal medicines. The global aromatherapy market has also witnessed a trend of self-medication as it avoids prescription requirement from any doctor. The restraints for the global aromatherapy market are that some scientific studies have found that aromatherapy only makes you feel better although there is no proof that it makes patient healthy and this type of treatments do not give quick results or rapid healing in major diseases. Some patients also have complained about allergies while taking aromatherapy treatment, so it is recommended to consult with aromatherapist before use of any essential oil for treatment.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1080

Aromatherapy Market: Segmentation

The global aromatherapy market is classified on the basis of application, product type and geography.

The global aromatherapy market is classified on the basis of application as follows:

  • Aerial diffusion
  • Direct inhalation
  • Topical application

The global aromatherapy market is classified on the basis of product type as follows:

  • Basil oil
  • Black pepper oil
  • Clove oil
  • Eucalyptus oil
  • Jasmin oil
  • Lavender oil
  • Lemon oil
  • Sandalwood oil
  • Tea tree oil
  • Other oils (Bergamot oil, Citronella oil, Geranium oil, Thyme oil, Yarrow oil)

Aromatherapy Market: Overview

In the past five years aromatherapy witnessed revolutionary demand as it follows self-medication procedure. Aromatherapy is widely used for the treatment of depression in patients owing to scientific studies which found that women facing depression problems were positively affected by the fragrance of oils and provided good cure. With rapid advancement and wide acceptance of aromatherapy treatments among patients, the global aromatherapy market is expected to expand at healthy CAGR during the forecast period.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1080

Aromatherapy Market: Region-wise outlook

Depending on geographic region, global aromatherapy market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Europe held largest share in the global market of aromatherapy followed by North America, Japan and Asia Pacific owing to high occurrence of several diseases and disorders, great advancement in field of aromatherapy and developed healthcare infrastructure. The developing nations in Asia Pacific, Middle East and Africa hold huge potential for growth in the global aromatherapy market, due to its affordable costs, less side-effects, excellent results and completely organic nature.

Aromatherapy Market: Key Players

Some of the key participating global players in aromatherapy global market are Heritage oils, Native American nutritionals, North American Herb and Spice, Mountain Rose Herbs, Aura Cacia, doTerra, Young living.

Full story

New Efficient Techniques for Health Monitoring Using Multiple Wearables

New Efficient Techniques for Health Monitoring Using Multiple Wearables

body-sensors

 

As body-worn sensors are becoming cheaper and easier to use, there arises the possibility of complex continuous health tracking using numerous devices all at once. Because they can use quite a bit of power as well as computing resources, to really make them practical one has to limit their energy and resource expenditure. Researchers at North Carolina State University have been working on making sure that such sensors only transmit important readings and organize these readings within data structures that will provide the most utility to clinicians.

Their approach is to continuously classify different states that the wearer is in, whether it be walking, running, or sitting, and to then transmit only data that doesn’t seem to fit what the person seems to be doing. So an increase in one’s heartbeat while sitting may be a sign of arrhythmic tachycardia, but if the same thing happens as a person starts running then the same heart readings can be ignored.

The researchers had grad students wear suits full of sensors and tested different data capture schemes to minimize power and data consumption while gathering interesting readings. For example, they identified that six seconds is enough time to classify what the person is doing at any one time. This means that every six seconds the system should update its readings and focus on spotting changes relevant to the new state.

The team will be presenting their research titled “Hierarchical Activity Clustering Analysis for Robust Graphical Structure Recovery,” at the 2016 IEEE Global Conference on Signal and Information Processing, Dec. 7-9 in Washington, D.C.

Via: North Carolina State…

Full story

Acuson Freestyle, a Wireless Interventional Ultrasound System from Siemens

Acuson Freestyle, a Wireless Interventional Ultrasound System from Siemens

Acuson Freestyle, a Wireless Interventional Ultrasound System from Siemens

Siemens has entered into an agreement to acquire Invensys Rail, the rail automation business of Invensys for approximately €2.2 billion (£1.742 billion). At the same time, the company plans to divest its baggage handling, postal and parcel sorting activities. Both planned transactions are part of the recently launched “Siemens 2014″ company program, which amongst others, is aimed at strengthening the company’s core activities. With revenues of approximately £800 million, Invensys Rail is a leading software based rail signaling and control company. The acquisition will expand Siemens’ presence in the growing global rail automation market. “Today’s moves are important measures to focus our core activities. We are exiting a non-core business with limited synergy potential while strengthening a resilient and high return business by combining two organizations with similar cultures and attractive synergy potential. The combined business will ensure profitable growth opportunities worldwide for the Siemens Infrastructure & Cities Sector,” said Roland Busch, CEO of Siemens Infrastructure & Cities. The transaction is subject to Invensys shareholder approval and regulatory clearances.

The planned divestment of the baggage handling, postal and parcel sorting activities will further focus the activities of the Siemens Infrastructure & Cities Sector. While the company is one of the leading players in postal automation, parcel and baggage handling systems with a global presence and an installed base around the world, there are few synergies with other Siemens Divisions due to the high mechanical content. It is a highly specialized niche business, dominated by mid-sized companies. The mid-single-digit profit margin business with revenue of approximately €900 million and around 3,600 employees shall be sold.

Invensys Rail shall be integrated into Siemens’ Rail Automation business in the Mobility and Logistics Division of the Infrastructure & Cities Sector. “With the addition of Invensys Rail we are in an excellent position to offer best-in-class solutions and technology to rail operators worldwide. The combination of two excellent organizations will create a truly global player in the Rail Automation business,” said Sami Atiya, CEO of Siemens’ Mobility and Logistics Division.

Invensys Rail has a strong footprint and a well established reputation with customers in the UK, Spain, the U.S. and Australia which will extend Siemens’ Rail Automation existing presence in countries such as Germany, Austria, Switzerland as well as China and India. In recent years, Invensys Rail has also successfully expanded its business into fast-growing emerging regions. The combined Invensys Rail and Siemens product portfolio will offer a full range of automation and optimization products, solutions and services, covering all customer segments.

The growth outlook of the global rail automation market is driven by increasing urbanization and the demand for enhanced mobility including new and extended mass transit and commuter systems. Overall the rail sector benefits also from trends such as energy efficiency, environmental factors, liberalization, deregulation and low-cost transportation requirements.

Significant synergy potential is expected from the combination of territories and technologies together with cost savings in procurement, portfolio, engineering and SG&A. Synergies of over €100 million are expected, to be fully achieved by 2018.

In its last fiscal year ending March 2012, Invensys Rail generated revenues of £775 million and operating profit before interest and taxes of £116 million, representing a 15% margin. Order intake (excluding framework agreements) was £991 million, including major awards in new countries such as Saudi Arabia and Turkey. As of March 2012, Invensys Rail’s total order book was £1,202 million and it currently employs around 3,200 employees.

Siemens provides integrated mobility solutions and already has a significant and established rail automation business with revenues of €1.4 billion, employing around 6,500 employees. Invensys Rail shall be integrated into this business, which is headquartered in Berlin, Germany. Siemens and Invensys Rail managers will form the new management team and Invensys Rail’s local expertise and relationships will be retained. The new constellation will combine the regional strengths of both organizations for the benefit of its customers.

The transaction is subject to Invensys shareholder approval which is expected to be voted on at a General Meeting planned for December 2012. Furthermore, consent by Invensys’ lenders, the UK pension regulator and anti-trust authorities is required. Overall Siemens will not take on any significant pension liabilities with the transaction. Siemens expects the transaction to close in the second quarter of calendar year 2013.

Siemens AG (Berlin and Munich) is a global powerhouse in electronics and electrical engineering, operating in the fields of industry, energy and healthcare as well as providing infrastructure solutions, primarily for cities and metropolitan areas. For over 165 years, Siemens has stood for technological excellence, innovation, quality, reliability and internationality. The company is the world’s largest provider of environmental technologies. Around 40 percent of its total revenue stems from green products and solutions. In fiscal 2012, which ended on September 30, 2012, revenue from continuing operations was €78.3 billion and income from continuing operations was €5.2 billion. At the end of September 2012, Siemens had around 370,000 employees worldwide on the basis of continuing operations. Further information is available on the Internet at: http://www.siemens.com.

This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as “expects,” “looks forward to,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will,” “project” or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to stockholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens’ management, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond Siemens’ control, affect Siemens’ operations, performance, business strategy and results and could cause the actual results, performance or achievements of Siemens to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements or anticipated on the basis of historical trends. These factors include in particular, but are not limited to, the matters described in Item 3: Risk factors of our most recent annual report on Form 20-F filed with the SEC, in the chapter “Risks” of our most recent annual report prepared in accordance with the German Commercial Code, and in the chapter “Report on risks and opportunities” of our most recent interim report.

Further information about risks and uncertainties affecting Siemens is included throughout our most recent annual and interim reports, as well as our most recent earnings release, which are available on the Siemens website, www.siemens.com, and throughout our most recent annual report on Form 20-F and in our other filings with the SEC, which are available on the Siemens website, www.siemens.com, and on the SEC’s website, www.sec.gov. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results, performance or achievements of Siemens may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Siemens neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Using ultrasound during interventional procedures can be a cumbersome proposition due to the heavy cables linking the transducer to the main device unit. Clinicians often have to reposition the ultrasound to gain better access to the patient, potentially overcoming obstacles like other cables, staff, and their feet. Siemens unveiled a new ultrasound system that uses a wireless transducer that eliminates the cable problem and offers a more natural approach. Here’s a quick demo of the Acuson Freestyle that we were able to capture from the floor of RSNA 2012:

Source : https://www.siemens.com/press/en/pressrelease/?press=/en/pressrelease/2012/healthcare/clinical-products/hcp201211006.htm

Full story

Updates on BrainLab’s iPhone Integrated System

Updates on BrainLab’s iPhone Integrated System

Updates on BrainLab’s iPhone Integrated System

We have previously mentioned that BrainLab‘s Digital Lightbox reminds us of a giant iPhone. Clearly agreeing with our way of thinking, last week at the American Academy of Orthopedic Surgeons we saw BrainLab demonstrate an implementation of their knee navigation software that simply uses an iPhone/iPod Touch, coupled with a passive tracking attachment and iPhone App. The iPhone, with attached markers, is used to identify bony landmarks on the knee, which are then fed into the BrainLab software for 3-D guidance of knee surgery. The iPhone screen is used as the display, both for marker placement prompting and leg-alignment indicators during the procedure. Using the motion tracking sensor and the iPhone as an input and display, rather than the other solutions BrainLab supports (shown below), reduces the footprint needed in the OR.

777734534 BrainLab Takes iPhone like Digital Lightbox to Next Logical Step

There is no mention of the iPhone version of their imaging suite on the BrainLab website, but the FDA 510(K) clearance given for its Uni-Knee software does not define the display technology used, seemingly allowing this configuration.

We recently mentioned the BrainLab system for identifying bony landmarks on the knee that utilizes an iPhone/iPod touch as a major component. BrainLab’s Marc Mackey has since contacted us and clarified a few points.

The iPod-based system is a stand alone computer assisted surgery system that will initially be available with apps for total hip and total knee replacement. The top target for this project was efficiency, with

a goal of being faster or time neutral to procedures using conventional instruments while achieving the benefits of improved alignment. We expect the 510(k) soon.

uuu4nn4nn Updates on BrainLabs iPhone Integrated System

Digital Lightbox could be called a “giant iPhone”, but BrainLAB did develop the multi-touch capability BEFORE the iPhone was launched! The idea is that you can hang it on the wall and interact with any medical images or information easily and quickly, rather than sit hunched over a desktop monitor.

Source : http://www.accessdata.fda.gov/cdrh_docs/pdf8/K080678.pdf

Full story

Latest X Prize Foundation Competition Offers $10 Million For a Tricorder

Latest X Prize Foundation Competition Offers $10 Million For a Tricorder

Latest X Prize Foundation Competition Offers $10 Million For a Tricorder

The X PRIZE Foundation and Qualcomm Join Forces to Develop a Competition to Enhance Integrated Digital Health

PLAYA VISTA, CA–(Marketwire – May 10, 2011) – The X PRIZE Foundation, the leading nonprofit organization solving the world’s Grand Challenges of our time by creating and managing large-scale, global incentivized competitions, today announced a collaboration with Qualcomm Incorporated to design the Tricorder X PRIZE, a $10 million prize to develop a mobile solution that can diagnose patients better than or equal to a panel of board certified physicians. The X PRIZE Foundation and Qualcomm seeks to achieve this by combining advancements in expert systems and medical point of care data such as wireless sensors, advancements in medical imaging and microfluidics.

The Tricorder X PRIZE aims to incentivize consumer empowerment in healthcare by extending the reach of health information and services to more people. This prize will bring understandable, easily accessible health information and metrics to consumers on their mobile devices, pointing them to earlier actions for care.

“For years, Qualcomm has been transforming lives by connecting people through incredible technologies,” said Dr. Peter Diamandis, Chairman and CEO of the X PRIZE Foundation. “The X PRIZE Foundation is honored to work with Qualcomm to positively affect health consumers by developing a prize that will revolutionize consumer’s access to health data and information.”

The collaboration between the X PRIZE Foundation and Qualcomm will bring together experts in technology usability, wireless sensors, cloud computing and mobile health to accelerate the convergence of these fields. The winning tool will enable consumers in any location to quickly and effectively assess health conditions, determine if they need professional help and answer the question, “What do I do next?”

“Qualcomm strives to provide a means to see choices, make decisions and get the right care faster and more conveniently. We believe this is a fundamental step in helping people become true ‘Health Consumers’ who can have as much say in assessing and accessing healthcare as they would any other service or product,” said Don Jones, Vice President of Wireless Health Strategy and Market Development at Qualcomm Labs. “Qualcomm believes the value of this X PRIZE is also in changing the cost structure and focus of healthcare. By having consumers take the initial actions to obtain health assessment data, the use and the quality of physicians’ time is improved.”

Eugene Wesley “Rod” Roddenberry, Jr., son of Star Trek creator, Gene Roddenberry, commented, “It is great to see two amazing organizations — the X PRIZE Foundation and Qualcomm — bring the technology of Star Trek to life and make the Tricorder a reality for people everywhere.”

The X PRIZE Foundation will be collaborating with industry experts and advisors to complete the Tricorder X PRIZE design in 2011. It expects to launch the competition in early 2012.

ABOUT THE X PRIZE FOUNDATION

Founded in 1995, the X PRIZE Foundation is the leading nonprofit organization solving the world’s Grand Challenges by creating and managing large-scale, high-profile, incentivized prize competitions that stimulate investment in research and development worth far more than the prize itself. The organization motivates and inspires brilliant innovators from all disciplines to leverage their intellectual and financial capital for the benefit of humanity. The X PRIZE Foundation conducts competitions in four Prize Groups: Education & Global Development; Energy & Environment; Life Sciences; and Exploration (Ocean and Deep Space). Prizes won include the $10 million Ansari X PRIZE for private, suborbital space flight; the $10 million Progressive Insurance Automotive X PRIZE for creating safe, affordable, production-capable vehicles that exceed 100 MPG energy equivalent (MPGe); and the $2 million Northrop Grumman Lunar Lander X PRIZE CHALLENGE for advanced rocket development. Active prizes include the $30 million Google Lunar X PRIZE, the $10 million Archon Genomics X PRIZE, and the $1.4 million Wendy Schmidt Oil Cleanup X CHALLENGE. For more information, visit www.xprize.org.

X Prize Foundation, the non-profit organization that has awarded millions of dollars for sub-orbital spacecraft and ultra-efficient automobiles, has announced a new competition in collaboration with Qualcomm. The competition (which is actually called the Tricorder X PRIZE) will award a $10 million prize to the developer of a mobile solution to diagnose patients as well, or better than, a panel of physicians.

According to the X Prize Foundation and Qualcomm, the winning design should integrate the latest in wireless sensors, medical imaging, microfluidics, and cloud computing. It should allow a user to assess health conditions anywhere, determine if they need further professional help, and overall answer the question, “What do I do next?”

The details of the competition are currently being decided, and the competition is expected to launch in early 2012, so get your creative juices flowing and help make yet another fictional piece of Star Trek technology become reality!

Source : http://www.marketwire.com/press-release/x-prize-foundation-qualcomm-join-forces-develop-competition-enhance-integrated-digital-1512263.htm

Full story

Fire Department iPhone App: There is a Hero in All of Us

Fire Department iPhone App: There is a Hero in All of Us

Fire Department iPhone App: There is a Hero in All of Us

Just admit it: deep in your heart you have always wanted to be an emergency medical technician, if at least for a few moments. If you are located in San Ramon Valley, California, you can now live that dream: the local fire department has released an iPhone app that will alert you of any emergency activity in the area. The well thought-out application will send out a push notification to users who have indicated that they are proficient in CPR whenever there is a cardiac emergency nearby. In addition, the closest public access AED is located by the app. Current response status of dispatched units are shown and incident locations are pinpointed on an interactive map. There is even a log of recent incidents including a photo gallery. For the old-school ham and scanner lads, it is possible to listen in on live emergency radio traffic. The app is available for free and below is a video with some more info.

Source : http://firedepartment.mobi/

Full story

The Stetheadphone: an iPhone Headphone for Doctors

The Stetheadphone: an iPhone Headphone for Doctors

The Stetheadphone: an iPhone Headphone for Doctors

The “I’m not product series” is continuing, The last one is “Stetheadphone”, created by Antrepo Design Industry. It is headset with remote and mic, you can make and receive calls, access voice-control features, and listen to and manage playback from your iPhone or iPod.

 

Material used is ultra light and flexible plastic for your comfort Also three sizes of soft silicone ear tips help you tailor a fit that’s right for you. The color options are white, black, pink, blue or green.

Antrepo, a design consultancy firm, has created a fabulous headphone for doctors that resembles a stethoscope. The Stetheadphone has all the features of the standard iPhone headphones, including making and receiving calls, voice-control, and listening to and managing music playback. There will be a wide range of colors available: white, black, pink, blue or green.

We are now in a research process to find a partner company for the production process. The companies interested in this product may contact Antrepo Design Industry through its website.

antrepo4.com

Other products of “i’m not product series”:

Traffitray, Spoticam, Salt&Pepper Cell, TunerTime, Minutuner, TimeTuner.

It is currently still a concept, but the company is looking for a partner company for the production process. Head over to the link below for some more pictures.

source : http://www.a2591.com/2010/05/im-not-doctor.html

Full story

Panasonic Develops A Novel Way to Sequence SNPs

Panasonic Develops A Novel Way to Sequence SNPs

Panasonic Develops A Novel Way to Sequence SNPs

Osaka, Japan – Panasonic, the leading brand by which Matsushita Electric Industrial Co., Ltd. is known, in collaboration with Professor Naoki Sugimoto of Konan University, has developed a technology for electrically identifying single nucleotide polymorphisms, or SNPs[1] (sequence variations in DNA[2]). This world-first technology* provides economical and accurate identification of SNPs by measuring electrical current without attaching DNA to electrodes.

This technology makes it possible to predict individuals’ responses to drugs and their risk of developing disease. In the future, this technology is expected to enable hospitals or clinics to provide patients with treatments and drugs tailored to their individual physical characteristics. With this new technology, Panasonic is contributing to a more personalized medical treatment based on the patient’s DNA sequence.

Conventional electrical SNP identification technologies, which use DNA-DNA hybridization reactions to identify the differences in DNA sequences, are not only inaccurate, but also require specialized and expensive electrodes to which artificial DNA needs to be attached.

Against this backdrop, Panasonic has achieved accurate SNP identification technology through the following new technologies:

Designing a base sequence of artificial DNA, for the DNA replication reaction, that depends strongly on the differences in DNA sequences.

Developing an electrical detection technology for phosphate compounds[3] released during DNA replication using the electrical current generated by enzyme reactions.

Return to Top

Technological Features

Accurate SNP identification using a DNA replication reaction that depends strongly on differences in DNA sequences

To identify SNPs by using a replication reaction for the target DNA an artificially synthesized piece of single-strand short DNA consisting of approximately 20 bases is prepared. The base sequence of this artificial DNA is designed to correspond to that of the target DNA. If the SNP of the target DNA is complementary to the SNP-corresponding nucleotide of the artificial DNA, the replication reaction of the artificial DNA occurs; however, the replication reaction does not occur if the SNP is not complementary. A SNP can be identified accurately by using this reaction.

The world’s first electrical SNP identification without attaching artificial DNA to an electrode

Conventional electrical SNP identification requires specialized and expensive electrodes, on which artificial testing DNA is attached. However, there are still problems in controlling the quantity to be secured and the variation in the result. Another approach is an optical identification method using fluorescent dyes without attaching DNA to an electrode, but this requires large and expensive equipment along with an optics system.

Panasonic’s improved new method can identify SNPs electrically with artificial DNA dissolved in a solution instead of being attached to the electrode.

Details of the Method

Technology for designing a base sequence of artificial DNA for a DNA replication reaction that depends strongly on the differences in DNA sequences

Panasonic discovered that when artificial DNA is prepared with a base sequence that is non-complementary to the second and third bases from the SNP of the target DNA, a replication reaction from the artificial DNA occurs if the SNP is complementary to the SNP-corresponding nucleotide; however, no replication reaction occurs if it is not complementary.

Electrical detection technology for phosphate compounds released during DNA replication as a ‘current value’ generated by enzyme reactions

During DNA replication, a single molecule of a phosphate compound called pyrophoric acid is released as a reaction byproduct every time a base is replicated. Panasonic has developed a new enzyme reaction system for converting the quantity of pyrophoric acid into an electrical current. By using three types of enzymes, the quantity of pyrophoric acid is converted to an equivalent quantity of potassium ferrocyanide, an electron mediator, making measurement of the oxidation current possible, a world-first achievement.

Image of SNP Sensor Chip

Patents: 24 in Japan, 22 overseas (including those pending)

 

[1] SNP (Single nucleotide polymorphism)

Of the individual differences seen in the DNA sequence, the condition where one base pair is different from the others, as well as its position, is called a SNP. The three billion base pairs that make up human DNA are thought to contain more than a million types of SNPs. This diversity of base pairs is believed to generate individual differences in each person’s reaction to drugs, development of diseases, and other health factors.

[2] DNA (Deoxyribonucleic acid)

All living organisms need to synthesize proteins, and the blueprint for this is DNA. The sequence of the four types of base (Adenine [A], Guanine [G], Cytosine [C], and Thymine [T]) controls the types of protein synthesized and their quantity. Two strands of DNA chains form a double helix. In this structure, ‘A’ specifically forms a base pair with ‘T,’ and ‘G’ with ‘C.’ (A combination of bases that can form a base pair is called complementary, and other combinations that cannot form a base pair are called non-complementary). One of the two strands can make a copy of the original DNA to transmit genetic information.

[3] Phosphate compounds

As a byproduct of the DNA replication process, one molecule of a phosphate compound, called pyrophoric acid, is released every time one base is replicated.

* As of August 20, 2008

About Panasonic

Best known for its Panasonic brand name, Matsushita Electric Industrial Co., Ltd. is a worldwide leader in the development and manufacture of electronic products for a wide range of consumer, business, and industrial needs. Based in Osaka, Japan, the company recorded consolidated net sales of 9.07 trillion yen (approx. US$90.52 billion) for the year ended March 31, 2008. The company’s shares are listed on the Tokyo, Osaka, Nagoya and New York (NYSE:MC) stock exchanges. For more information on the company and the Panasonic brand, visit the company’s website at http://panasonic.net/.

Matsushita of Japan, commonly known as Panasonic, has developed a technique to electronically identify single nucleotide polymorphisms in a DNA solution without direct contact between the molecules and electrodes. Knowledge of one’s DNA variance (in the form of nucleotide polymorphisms) can point to differences in individual response to specific pharmaceuticals, as well as risks of having a certain disease.

Details of the technology:

To identify SNPs by using a replication reaction for the target DNA an artificially synthesized piece of single-strand short DNA consisting of approximately 20 bases is prepared. The base sequence of this artificial DNA is designed to correspond to that of the target DNA. If the SNP of the target DNA is complementary to the SNP-corresponding nucleotide of the artificial DNA, the replication reaction of the artificial DNA occurs; however, the replication reaction does not occur if the SNP is not complementary. A SNP can be identified accurately by using this reaction.

Conventional electrical SNP identification requires specialized and expensive electrodes, on which artificial testing DNA is attached. However, there are still problems in controlling the quantity to be secured and the variation in the result. Another approach is an optical identification method using fluorescent dyes without attaching DNA to an electrode, but this requires large and expensive equipment along with an optics system.

Panasonic’s improved new method can identify SNPs electrically with artificial DNA dissolved in a solution instead of being attached to the electrode.

Panasonic discovered that when artificial DNA is prepared with a base sequence that is non-complementary to the second and third bases from the SNP of the target DNA, a replication reaction from the artificial DNA occurs if the SNP is complementary to the SNP-corresponding nucleotide; however, no replication reaction occurs if it is not complementary.

During DNA replication, a single molecule of a phosphate compound called pyrophoric acid is released as a reaction byproduct every time a base is replicated. Panasonic has developed a new enzyme reaction system for converting the quantity of pyrophoric acid into an electrical current. By using three types of enzymes, the quantity of pyrophoric acid is converted to an equivalent quantity of potassium ferrocyanide, an electron mediator, making measurement of the oxidation current possible, a world-first achievement.

Source : http://panasonic.co.jp/corp/news/official.data/data.dir/en080819-2/en080819-2.html

Full story

Kaiser Permanente Makes Electronic Medical Records Accessible to Patients

Kaiser Permanente Makes Electronic Medical Records Accessible to Patients

Kaiser Permanente Makes Electronic Medical Records Accessible to Patients Through Android App and Mobile Website

Nearly 9 Million Kaiser Permanente Health Records Securely Available on Mobile Devices

Patient information securely available with a touch of a finger with new app and mobile-optimized kp.org

OAKLAND, Calif. — Kaiser Permanente already has the largest electronic medical record system in the world. Today, the health care organization announced that 9 million Kaiser Permanente patients now can easily access their own medical information anywhere in the world on mobile devices through a mobile-optimized website.

Nearly 9 Million Kaiser Permanente Health Records Securely Available on Mobile Devices

Kaiser Permanente has released a new app for Android devices, and users of other mobile devices, including the iPhone, can also get full access to that information from the Kaiser Permanente health record system with the mobile-optimized version of kp.org. An additional app for iPhone will be released in the coming months, but iPhone users can easily download a shortcut icon onto their home screens that will take them directly to the mobile-friendly kp.org with a touch of the finger.

Kaiser Permanente has led the health care world in providing online access to information for its patients. In 2011 alone, more than 68 million lab test results were made available online to Kaiser Permanente patients. The mobile-optimized site and the new app make that information, and much more, securely available at members’ fingertips.

Kaiser Permanente patients will have 24/7 access to lab results, diagnostic information, direct and secure email access to their doctors, and will also be able to order prescription refills. Kaiser Permanente patients have been able to email their doctors for five years, with more than 12 million e-visits in 2011 alone. Kaiser Permanente expects that number to increase significantly with the new app and mobile-optimized site.

The Android app is available now in the Android Market at no charge. Users of other mobile devices can access the same set of care-support tools at no charge through the new secure, mobile-optimized member website, which is available through smart-phone Internet browsers.

With the new offering, Kaiser Permanente patients have 24/7 access from their mobile devices to view their secure personal health record, email their doctors, schedule appointments, refill prescriptions and locate Kaiser Permanente medical facilities. Members who have the ability to act on behalf of a family member on kp.org now can accomplish the same tasks. Those caring for an elderly parent or someone with a chronic condition can now more easily check lab results, refill prescriptions and communicate with the doctor’s office on behalf of the patient.

“This is the future of health care. Health care needs to be connected to be all that it can be. This new level of connectivity is happening real time, and it is happening on a larger scale than anything like it in the world,” said George Halvorson, chairman and chief executive officer of Kaiser Permanente. “The fact that a Kaiser Permanente patient in an emergency room in Paris or Tokyo can simply pull out their mobile device and have immediate and current access to their own medical information is an evolutionary and revolutionary breakthrough for medical connectivity.”

“Our members love our current connectivity tools,” said Christine Paige, senior vice president of marketing and Internet services. “Now we will extend our entire connectivity tool kit for patients through a mobile phone. Our mobile-optimized site and app take connectivity to the next level by making the mobile experience easy and enjoyable. We believe that convenience, paired with a great user experience, will meet members’ needs and will ultimately result in improved health and patient-physician relationships.”

iPHONE SHORTCUT ICON

Go to kp.org on your iPhone mobile Web browser

Click on the middle icon at the bottom of your screen

Choose “Add to Home Screen”

A short cut will be added to your iPhone icons

Members using the Android app have access to their kp.org accounts by touching the app icon on their phones. Those visiting kp.org from a mobile phone Internet browser are seamlessly redirected to the mobile-optimized website, which was designed for optimal viewing on a mobile-phone screen. In both cases, a streamlined menu of mobile-optimized features helps members find what they need quickly and easily with minimal taps.

“Providing our patients with clear and convenient access to their health information is a step forward in connectivity and improving the health care experience for patients, no matter where they are,” said Jack Cochran, MD, executive director of The Permanente Federation. “We already have complete connectivity among Kaiser Permanente care sites through Kaiser Permanente HealthConnect®. This new level of connectivity extends the reach of information to our patients in a more convenient and user-friendly format. This new app and mobile-optimized site is very good for patient care and will revolutionize connectivity by bringing health care for the first time to the level of connectivity other parts of our economy have achieved.”

Users’ personal health information is safe and secure while using the new app and the mobile-friendly kp.org, which employ the same security safeguards that protect patient information on the traditional kp.org website, including secure sign-on and automatic sign-out after a period of inactivity.

“The benefits of mobile extend beyond member engagement,” said Philip Fasano, executive vice president and chief information officer of Kaiser Permanente. “Mobile solutions can have a positive impact on health. Health care, itself, will be much more convenient for many people. The mobile-friendly site and app are also a springboard for new innovations that will inspire members to be aware of their health and take steps to improve it.”

The Pew Internet Project reported that 40 percent of American adults access the Internet via their mobile phones, and in some cases, mobile phones are their primary source of Internet access. Twenty-five percent of smart-phone owners go online primarily using their phone; of these, roughly one-third have no high-speed home broadband connection.

“There has been an explosion in the growth of mobile devices and users are looking for new and improved ways to manage their lives online,” Halvorson said. “It is time to make health information easily accessible from mobile devices.”

“Edelman’s 2011 Health Barometer reported that 68 percent of those who use digital tools to manage or track their health believed it helped them improve their health,” Paige said. “Nearly 80 percent of kp.org users agreed that the website helps them stay healthy. The tools and services available on kp.org are even more powerful in the palm of your hand.”

This is a major new connectivity offering, but it is not Kaiser Permanente’s first mobile app. Other, more targeted tools, were released earlier. Kaiser Permanente launched its first mobile application, KP Locator for iPhone, in July 2011. The facility-finder app has been downloaded 42,000 times. KP Locator combines the power of kp.org’s robust facility directory and the iPhone’s GPS capabilities to make searching for Kaiser Permanente facilities fast and easy for patients on the go. It answers three of the most basic, but vital, user questions thoroughly and simply — where are the Kaiser Permanente locations close to me, how can I contact and get to them, and what departments and services can I access there? Kaiser Permanente also released its Every Body Walk! app two months ago to help encourage people to walk and maintain healthy activity levels, and that app was rated No. 5 in the Top 100 Green Apps by Eco-Libris.

Kaiser Permanente is known for its leadership in the use of health information technology. The Kaiser Permanente electronic health record is the largest non-governmental medical record system in the world. KP HealthConnect enables all of Kaiser Permanente’s nearly 16,000 physicians to electronically access the medical records of all 8.9 million Kaiser Permanente members nationwide and serves as a model for other care systems. Kaiser Permanente has received numerous awards for its health IT expertise, including four 2011 eHealthcare Leadership Awards. You can learn more about how patients, clinicians and researchers are using My Health Manager and KP HealthConnect by checking out Kaiser Permanente’s YouTube channel: www.youtube.com/kaiserpermanenteorg. Kaiser Permanente also has what might be the world’s most complete electronic medical library to support its caregivers by providing convenient access to the best and most current medical science. That electronic medical library is for internal use only.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We serve approximately 8.9 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.

Kaiser Permanente, the largest managed care organization in the United States, has unveiled an Android app and mobile-optimized website through which its 9 million patients can access their own medical information anywhere in the world on their mobile devices. The app and mobile website contain the same information and possibilities that were already available through kp.org, i.e. lab results, diagnostic information, secure email access to doctors, ordering of prescription refills, scheduling appointments and locating of healthcare facilities. It is also possible for family members to get access on behalf of a patient and accomplish the same tasks.

The Android app is available for free from the Android market. An iPhone app will be released in the coming months, but for now iPhone users will have to do with the mobile website.

Source : http://xnet.kp.org/newscenter/pressreleases/nat/2012/012412kporgmobileoptimized.html

Full story

HealthPal Wireless Monitoring System Going on Sale in Canada, EU

HealthPal Wireless Monitoring System Going on Sale in Canada, EU

HealthPal Wireless Monitoring System Going on Sale in Canada, EU

A wireless system to transmit daily glucose readings from a patient’s glucometer via cellphone into a central server, developed by a Scottsdale, Arizona startup MedApps, Inc., has been approved by the FDA for for over-the-counter use. We have briefly mentioned this system about a year ago.

62345ww2 MedApps D PAL™ Remote Patient Monitoring System for DiabetesHere’s how this telemedicine system works:

D-PAL currently combines with the Polymap Polytel(R) device which connects to the LifeScan(R) OneTouch(R) Ultra(R) and sends the data via Bluetooth(R) (wireless) to the patient’s cell phone (acting as a “Hub”) and transmits the information to the central server in near real-time. D-PAL is the first of a series of medical devices that integrates with the MedApps System and enables patients with chronic diseases to lead more active lifestyles. Additional integrated devices will include scales, blood pressure monitors, spirometers, pulse oximeters, ECG, and a variety of implantable devices such as pacemakers.

Pre-established thresholds are set for each patient by their healthcare provider(s). When a reading occurs outside of these thresholds, an alert may occur and the patient may be contacted using a pre-determined mode. One

such mode is an interactive voice response system which can qualify additional behavioral information by asking questions such as, “Have you exercised today?” or “Have you taken your medication?” The responses to these questions, combined with previously collected biometric data, can give healthcare professionals greater insight into a patient’s health.

The MedApps Telemedicine 2.0 Wireless System, allows medical providers to monitor trends in their patients’ health with accurate, timely readings. Healthcare professionals and patient management companies have greater accessibility to better information and no longer have to rely on patients to submit their own readings, while the patient, in turn, is encouraged to live a more active lifestyle. As patients lose mobility, they must curtail daily activities, in essence giving “control” of their lives to their disease. This loss of control signals a downward spiral toward immobilization, inpatient encounters, and costly ER visits. MedApps helps stabilize patient treatments, allows timely interventions, and gives patients more control over their diseases.

MedApps of Scottsdale, Arizona has received European and Canadian approvals for its mobile health telemetry reporting system. The company’s flagship product, HealthPal, interfaces with medical devices like glucometers to wirelessly transmit data to a health care providers or to personal health record management systems, such as Microsoft HealthVault and Google Health. The system, which works just about anywhere in the world over GSM, GPRS, and M2M cellular networks, already has FDA approval for marketing in the US.

aala234l HealthPal Wireless Monitoring System Going on Sale in Canada, EU

Built-in Timer

- Programmable Reminder to Assist in Compliance

Rechargeable Power Source

- Long-life Lithium Polymer Battery

Audio Speaker

- Gives Connected Devices Audio Capability

Multi-Lingual Capability

- Pre-Program to speak in the User’s Language

Audio Earphone Jack

- Allows User to Review / Listen to Audio Discreetly

DIMENSIONS

- Size: 109 mm x 54 mm x 23 mm

- Weight: Approx. 3 ounces

Embedded Wireless Technology

- M2M Cellular, CDMA (pending), GSM, Bluetooth, GPS

Adaptable Technology

- Interchangeable Smart Cables

- Multiple Cellular Networks

- Expandable Memory

OLED Display Screen

- Intuitive User Feedback

- On-screen Menu Features

Easy to Use Control Pad

- One Touch Functions

- Access Menu Features

mobihealthnews

News

About

Contact

Advertise

Research

MedApps attains CE Mark, eyes Europe, Canada

By: Brian Dolan | Jan 4, 2010 3 0 0

Tags: AT&T | CE Mark | chronic disease management | FCC | FDA | HealthPAL | MedApps | regulation | Verizon |

MedApps HealthPalWireless remote monitoring company MedApps announced that it has received ISO 13485:2003 and ISO 9001:2008 certification from Underwriters Laboratories (UL), which subsequently led to a CE Mark certification and CMDCAS approval, enabling the company to market its products throughout Europe and Canada.

To date, MedApps has secured two FDA clearances, various FCC certifications, AT&T and Verizon certifications in addition to the recent ISO 13485 / 9001 and CE Mark certification, according to the company’s CEO and Founder Kent Dicks.

MedApps’ core product offering today is HealthPAL, a device that is about the size of a cell-phone but with fewer buttons. The company explains that the buttons are for special features and set-up, and that the reading and data transmissions are automated. In other words: “The patient does not push any buttons, navigate any screen commands or touch the HealthPAL in any fashion.” HealthPAL can synch to off-the-shelf personal medical devices like blood glucose meters for wireless, remote chronic disease management. MedApps has plans to launch a whole suite of form factors for devices or applications in the coming year.

“Although the stringent process has taken significant resources in time and energy, the investment has put us ahead of others in the telehealth space. I personally take extreme pride in knowing that all of us at MedApps have put our best foot forward to do it right from the very beginning, and we’ve built our system on a solid regulatory foundation,” Dicks stated in a company press release.

source : http://mobihealthnews.com/5907/medapps-attains-ce-mark-eyes-europe-canada/

Related Posts Plugin for WordPress, Blogger...

Full story

Page 1 of 1212345...10...Last »
Copyright © 2017 Medical Technology & Gadgets Blog MedicalBuy.net. All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes